Browsing by Author Lucano-Landeros, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2009Adenoviral delivery of dominant-negative transforming growth factor ? type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.; Marquez-Aguirre, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Sandoval-Rodriguez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Gonzalez-Cuevas, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Bueno-Topete, M., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Navarro-Partida, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Arellano-Olivera, I., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Lucano-Landeros, S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Armendariz-Borunda, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico, OPD Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
2009Adenoviral delivery of dominant-negative transforming growth factor β type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.; Marquez-Aguirre, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Sandoval-Rodriguez, A., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Gonzalez-Cuevas, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Bueno-Topete, M., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Navarro-Partida, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Arellano-Olivera, I., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Lucano-Landeros, S., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico; Armendariz-Borunda, J., Institute for Molecular Biology in Medicine and Gene Therapy, University of Guadalajara, Department of Molecular Biology and Genomics, PO Box 2-123, Guadalajara, Jalisco 44281, Mexico, OPD Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
2011Combinatorial gene therapy induces regression of hepatic encephalopathyGalvez-Gastelum, F.J.; Garcia-Bauelos, J.J.; Beas-Zárate, Carlos; Segura-Flores, A.; Gonzalez, H.; Chaparro-Huerta, V.; Salazar-Montes, A.; Sandoval-Rodriguez, A.S.; Bueno-Topete, M.; Lucano-Landeros, S.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Armendariz-Borunda, J.; Gálvez-Gastélum, F.J., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Garcia-Bãuelos, J.J., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Beas-Zárate, C., Laboratory of Molecular and Cell Neurobiology, CIBO, University of Guadalajara, Mexico; Segura-Flores, A., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; González, H., Research and Pharmaceutical Development Laboratory, Pharmacology Department, University of Guadalajara, Mexico; Chaparro-Huerta, V., Laboratory of Molecular and Cell Neurobiology, CIBO, University of Guadalajara, Mexico; Salazar-Montes, A., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Sandoval-Rodriguez, A.S., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Bueno-Topete, M., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Lucano-Landeros, S., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Medina-Preciado, D., OPD Civil Hospital, Guadalajara, Mexico; Gonzalez-Garcia, I., OPD Civil Hospital, Guadalajara, Mexico; Armendariz-Borunda, J., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico, OPD Civil Hospital, Guadalajara, Mexico; Beas-Zárate, Carlos., Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud
2011Combinatorial gene therapy induces regression of hepatic encephalopathyGalvez-Gastelum, F.J.; Garcia-Bauelos, J.J.; Beas-Zárate, Carlos; Segura-Flores, A.; Gonzalez, H.; Chaparro-Huerta, V.; Salazar-Montes, A.; Sandoval-Rodriguez, A.S.; Bueno-Topete, M.; Lucano-Landeros, S.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Armendariz-Borunda, J.; Gálvez-Gastélum, F.J., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Garcia-Báuelos, J.J., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Beas-Zárate, C., Laboratory of Molecular and Cell Neurobiology, CIBO, University of Guadalajara, Mexico; Segura-Flores, A., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; González, H., Research and Pharmaceutical Development Laboratory, Pharmacology Department, University of Guadalajara, Mexico; Chaparro-Huerta, V., Laboratory of Molecular and Cell Neurobiology, CIBO, University of Guadalajara, Mexico; Salazar-Montes, A., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Sandoval-Rodriguez, A.S., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Bueno-Topete, M., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Lucano-Landeros, S., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico; Medina-Preciado, D., OPD Civil Hospital, Guadalajara, Mexico; Gonzalez-Garcia, I., OPD Civil Hospital, Guadalajara, Mexico; Armendariz-Borunda, J., Institute for Molecular Biology and Gene Therapy, CUCS, University of Guadalajara, Jalisco, Mexico, OPD Civil Hospital, Guadalajara, Mexico; Beas-Zárate, Carlos., Universidad de Guadalajara. Centro Universitario de Ciencias de la Salud
2013Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: Association of TGF-? polymorphismsVeras-Castillo, E.R.; Cardenas-Camarena, L.; Lyra-Gonzalez, I.; Munoz-Valle, J.F.; Lucano-Landeros, S.; Guerrerosantos, J.; Gonzalez-Ulloa, B.; Mercado-Barajas, J.L.; Sanchez-Parada, M.G.; Azabache-Wennceslao, R.; Armendariz-Borunda, J.; Veras-Castillo, E.R., Instituto Jalisciense de Cirug�a Reconstructiva Dr. Jos� Guerrerosantos, Guadalajara, Jalisco, Mexico; Cardenas-Camarena, L., Instituto Jalisciense de Cirug�a Reconstructiva Dr. Jos� Guerrerosantos, Guadalajara, Jalisco, Mexico; Lyra-Gonzalez, I., Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Mu�oz-Valle, J.F., IIRSME, CUCS, Universidad de Guadalajara, Guadalajara Jalisco, Mexico; Lucano-Landeros, S., Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Guerrerosantos, J., Instituto Jalisciense de Cirug�a Reconstructiva Dr. Jos� Guerrerosantos, Guadalajara, Jalisco, Mexico; Gonzalez-Ulloa, B., Diagn�stico Especializado Por Imagen DEI, Zapopan, Jalisco, Mexico; Mercado-Barajas, J.L., Departamento de Ciencias Sociales, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Sanchez-Parada, M.G., Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Azabache-Wennceslao, R., Instituto Jalisciense de Cirug�a Reconstructiva Dr. Jos� Guerrerosantos, Guadalajara, Jalisco, Mexico; Armendariz-Borunda, J., Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, OPD Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
2013Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: Association of TGF-β polymorphismsVeras-Castillo, E.R.; Cardenas-Camarena, L.; Lyra-Gonzalez, I.; Munoz-Valle, J.F.; Lucano-Landeros, S.; Guerrerosantos, J.; Gonzalez-Ulloa, B.; Mercado-Barajas, J.L.; Sanchez-Parada, M.G.; Azabache-Wennceslao, R.; Armendariz-Borunda, J.; Veras-Castillo, E.R., Instituto Jalisciense de Cirugía Reconstructiva Dr. José Guerrerosantos, Guadalajara, Jalisco, Mexico; Cardenas-Camarena, L., Instituto Jalisciense de Cirugía Reconstructiva Dr. José Guerrerosantos, Guadalajara, Jalisco, Mexico; Lyra-Gonzalez, I., Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Muñoz-Valle, J.F., IIRSME, CUCS, Universidad de Guadalajara, Guadalajara Jalisco, Mexico; Lucano-Landeros, S., Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Guerrerosantos, J., Instituto Jalisciense de Cirugía Reconstructiva Dr. José Guerrerosantos, Guadalajara, Jalisco, Mexico; Gonzalez-Ulloa, B., Diagnóstico Especializado Por Imagen DEI, Zapopan, Jalisco, Mexico; Mercado-Barajas, J.L., Departamento de Ciencias Sociales, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Sanchez-Parada, M.G., Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Azabache-Wennceslao, R., Instituto Jalisciense de Cirugía Reconstructiva Dr. José Guerrerosantos, Guadalajara, Jalisco, Mexico; Armendariz-Borunda, J., Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, OPD Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
2014Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.; Flores-Contreras, L., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Sandoval-Rodríguez, A.S., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Mena-Enriquez, M.G., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Lucano-Landeros, S., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Arellano-Olivera, I., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico, Unidad Médica de Alta Especialidad, Hospital de Especialidades Centro Medico Nacional de OccidenteGuadalajara, Jalisco, Mexico; Álvarez-Álvarez, A., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Sanchez-Parada, M.G., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Armendáriz-Borunda, J., Departamento de Biología Molecular y Genómica, Instituto de Biología Molecular en Medicina y Terapia Génica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico, INNOVAREGuadalajara, Jalisco, Mexico
2014Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.; Flores-Contreras, L., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Sandoval-Rodr�guez, A.S., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Mena-Enriquez, M.G., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Lucano-Landeros, S., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Arellano-Olivera, I., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico, Unidad M�dica de Alta Especialidad, Hospital de Especialidades Centro Medico Nacional de OccidenteGuadalajara, Jalisco, Mexico; �lvarez-�lvarez, A., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Sanchez-Parada, M.G., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico; Armend�riz-Borunda, J., Departamento de Biolog�a Molecular y Gen�mica, Instituto de Biolog�a Molecular en Medicina y Terapia G�nica, CUCS, Universidad de Guadalajara, Sierra Mojada # 950Guadalajara, Jalisco, Mexico, INNOVAREGuadalajara, Jalisco, Mexico